ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406
SHANGHAI, April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
INTREPID Alliance Launches Antiviral Toolbox to Support Global Research Community
Open-access resource includes Registry of Antiviral Compound Libraries to help catalyze drug…
